Post-translational regulation of APOBEC3A in breast cancer
Washington State University · 01.01.2024
DOI: 10.7273/000007034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Washington State University, erschienen am 01.01.2024. Verfasst von Christopher D. Collins.
Abstract (Originalsprache)
Cancer is the 2nd leading cause of death in the US and is generally characterized by the accumulation of mutations that activate oncogenes or silence tumor suppressor genes. These mutations are the result of DNA damage with both endogenous and exogenous sources. Mutations that decrease the fidelity of DNA replication or repair machinery promote genome instability, which can promote further mutagenesis. This is especially problematic in tumors where accumulation of new mutations increases the heterogeneity, increasing the risk of clonal populations developing mechanisms for metastasis or evading therapies.
Schlagwörter
Zitieren
APA
Collins, C. D. (2024). Post-translational regulation of APOBEC3A in breast cancer. Washington State University. https://doi.org/10.7273/000007034
Vancouver
Collins CD. Post-translational regulation of APOBEC3A in breast cancer. Washington State University. 2024. doi:10.7273/000007034
BibTeX
@article{Collins2024,
author = {Collins, Christopher D.},
title = {Post-translational regulation of APOBEC3A in breast cancer},
journal = {Washington State University},
year = {2024},
doi = {10.7273/000007034}
}
EUVIMED